Skip to main content

Table 2 Baseline patient characteristics

From: Complete versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: a meta-analysis of randomized trials

Study Number (CR/IRA-only) (n) Male (CR/IRA-only) (%) Age (CR/IRA-only) (years) Hypertension (CR/IRA-only) (%) Diabetes (CR/IRA-only) (%) Previous MI (CR/IRA-only) (%) Smoking (CR/IRA-only) (%)
COMPARE-ACUTE 2017 [7] 295/590 79/76 62/61 46/48 15/16 7.5/8.1 41/49
Hamza et al. 2016 [10] 50/50 82/86 56/52 26/36 100/100 10/6 72/78
DANAMI-3- PRIMULTI 2015 [6] 314/313 80/81 64/63 41/47 9/13 5/9 51/48
PRAGUE − 132,015 [11] 106/108 NA NA NA NA NA NA
CvLPRIT 2015 [12] 150/146 85/77 64/65 37/36 13/14 4.8/3.6 34/37
PRAMI 2013 [13] 234/231 76/81 62/62 40/40 15/21 8/7 50/45
Ghani et al. 2012 79/40 80/81 62/61 26/43 6.3/5.0 6.3/4.9 44/48
Politi et al. 2010 [14] 130/84 77/78 65/67 57/60 23/24 NA NA
HELP AMI 2004 [15] 52/17 88/85 64/65 37/59 12/41 NA 67/81
Study Anterior MI (CR/IRA-only) (%) Procedure time (CR/IRA-only) (min) Contrast Media (CR/IRA-only) (ml) Glycoprotein IIb/IIIa Inhibitors (CR/IRA-only) (%) DES (CR/IRA-only) (years)
COMPARE-ACUTE 2017 [7] 36/35 65/59 224/202 22/25 95/96
Hamza et al. 2016 [10] 48/46 NA NA 38/34 100/100
DANAMI-3- PRIMULTI 2015 [6] 33/36 76/42 280/170 20/23 95/93
PRAGUE − 132,015 [11] NA NA NA NA NA
CvLPRIT 2015 [12] 36/36 55/41 250/190 32/32 96/91
PRAMI 2013 [13] 29/39 63/45 300/200 79/78 63/58
Ghani et al. 2012 [14] NA NA NA 45/46 23/17
Politi et al. 2010 [15] 48/42 NA NA 100/100 NA
HELP AMI 2004 [16] 52/59 53/69 341/242 75/82 0/0
  1. CR complete revascularization, IRA infarct-related artery only, DES drug-eluting stent, NA not available